<DOC>
	<DOCNO>NCT00497198</DOCNO>
	<brief_summary>The objective study evaluate efficacy MCI-196 patient Type 2 Diabetes base change blood glucose-related parameter safety 12 week administration double-blind , placebo-controlled manner . And addition , change lipid-related parameter examine .</brief_summary>
	<brief_title>Efficacy Safety Study MCI-196 Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Patients whose fast blood glucose level observation period 130mg/dL 200mg/dL . Patients whose HbA1c 7.0 % observation period . Patients serious cardiac , hepatic renal complication . Patients serious diabetic complication . Patients complete biliary obstruction ileus . Pregnant , lactating , probably pregnant patient , patient agree contraception .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>anion-exchange resin</keyword>
</DOC>